Evidence map›Paper›PMID 37034202›Full record

ArticleAmerican journal of cancer research2023

Integration of clinical features and sociodemographic factors: a simplified prognostic model for patients with multiple myeloma based on a double-center retrospective analysis.

Jiaxuan Xu, Ruoyi Wang, Qiaoyan Han, Yifan Zuo, Jingjing Sun, Bing Chen, Xiaoqing Dong

Abstract read
In one paragraph

Article in American journal of cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiaxuan XuDepartment of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing, Jiangsu, China.
Ruoyi WangDepartment of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing, Jiangsu, China.
Qiaoyan HanDepartment of Hematology, Jingjiang People's Hospital Jingjiang, Jiangsu, China.
Yifan ZuoDepartment of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing, Jiangsu, China.
Jingjing SunDepartment of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing, Jiangsu, China.
Bing ChenDepartment of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing, Jiangsu, China.
Xiaoqing DongDepartment of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to develop and validate a prognostic nomogram that combines clinical and sociodemographic factors of patients with newly diagnosed multiple myeloma (MM). A total of 257 newly diagnosed patients with MM from two independent medical centers in China were included in this retrospective cohort study. Univariate and multivariate Cox regression models were used to identify independent risk factors and to construct the nomogram. The predictive ability of the nomogram was evaluated using the areas under the curve (AUCs) and calibration curves. K-fold cross-validation was employed for internal validation of the nomogram performance. Moreover, a stratification system to determine risk level was generated based on the nomogram. Hemoglobulin, creatinine, rurality, and marital status were significantly associated with overall survival (OS) and were incorporated into the nomogram for OS prediction. The prognostic nomogram showed good discrimination and accuracy, and its predictive capability was superior to the International Staging System. The AUC values predicting the 1-, 3-, and 5-year OS probabilities of the nomogram were 0.775, 0.755, and 0.754, respectively. Subsequently, patients were classified into high- and low-risk subgroups based on the median total points of the nomogram; this risk stratification clearly distinguished between high- and low-risk MM patients with significantly different clinical outcomes (median OS: 27 months vs. 84 months). We established a novel prognostic prediction model by comprehensively incorporating clinical and sociodemographic variables, which can effectively predict the survival outcomes in patients with MM.

Indexed as

Multiple myelomanomogramprognostic modelrisk stratificationsociodemographic factors

Identifiers

PMID37034202
PMCPMC10077056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.